Predict your next investment

Non-Profit Foundation
silversteinfoundation.org

See what CB Insights has to offer

Investments

2

Portfolio Exits

1

About The Silverstein Foundation for Parkinson's with GBA

The Silverstein Foundation is a 501(c)(3) non-profit organization focused on investing in cutting-edge therapeutic approaches for the treatment and prevention of Parkinson's disease in glucocerebrosidase (GBA) mutation carriers. The Foundation collaborates with clinicians, scientists, and biotechnology companies to accelerate research and clinical trials in an effort to rapidly bring new disease-modifying therapeutic options to patients.

The Silverstein Foundation for Parkinson's with GBA Headquarter Location

Ansonia Station P.O. Box 237137

New York, New York, 10023,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

The Silverstein Foundation for Parkinson's with GBA Investments

2 Investments

The Silverstein Foundation for Parkinson's with GBA has made 2 investments. Their latest investment was in Chamishi Therapeutics as part of their Seed on September 9, 2019.

CBI Logo

The Silverstein Foundation for Parkinson's with GBA Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

9/26/2019

Seed

Chamishi Therapeutics

$0.49M

Yes

2

2/26/2019

Grant

Subscribe to see more

Subscribe to see more

10

Date

9/26/2019

2/26/2019

Round

Seed

Grant

Company

Chamishi Therapeutics

Subscribe to see more

Amount

$0.49M

New?

Yes

Subscribe to see more

Co-Investors

Sources

2

10

The Silverstein Foundation for Parkinson's with GBA Portfolio Exits

1 Portfolio Exit

The Silverstein Foundation for Parkinson's with GBA has 1 portfolio exit. Their latest portfolio exit was Gain Therapeutics on March 18, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

3/18/2021

IPO

$99M

Public

4

Date

3/18/2021

Exit

IPO

Companies

Valuation

$99M

Acquirer

Public

Sources

4

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.